Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Germ”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT07007117
What this trial is testing

PHOX2B PC-CAR T Cells for Relapsed Neuroblastoma

Who this might be right for
Refractory NeuroblastomaRelapsed NeuroblastomaHigh-Risk Neuroblastoma
Stephan Grupp MD PhD 38
Early research (Phase 1)Study completedNCT01273090
What this trial is testing

Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsLymphomaLymphoproliferative Disorder+2 more
Children's Oncology Group 34
Early research (Phase 1)Ended earlyNCT04239040
What this trial is testing

GVAX Plus Checkpoint Blockade in Neuroblastoma

Who this might be right for
NeuroblastomaPediatric Solid Tumor
Dana-Farber Cancer Institute 19
Testing effectiveness (Phase 2)Ended earlyNCT03435640
What this trial is testing

REVEAL Study of NKTR-262 in Combination With NKTR-214 and Nivolumab in Patients With Locally Advanced / Metastatic Solid Tumor Malignancies

Who this might be right for
MelanomaMerkel Cell CarcinomaTriple Negative Breast Cancer+4 more
Nektar Therapeutics 64
Testing effectiveness (Phase 2)Study completedNCT00002508
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell Tumors

Who this might be right for
Extragonadal Germ Cell TumorOvarian CancerTesticular Germ Cell Tumor
Temple University
Not applicableStudy completedNCT07017790
What this trial is testing

Amino Acid PET to Assess the Efficacy of IDH Inhibitor Treatments for IDH Mutated Gliomas

Who this might be right for
Glioma
Central Hospital, Nancy, France 22
Testing effectiveness (Phase 2)Study completedNCT00003518
What this trial is testing

Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors

Who this might be right for
Ovarian CancerTesticular Germ Cell Tumor
Eastern Cooperative Oncology Group 44
Testing effectiveness (Phase 2)Ended earlyNCT05200143
What this trial is testing

Study of Ipilimumab, Nivolumab, and Cabozantinib in Patients With Cutaneous Melanoma

Who this might be right for
Refractory Cutaneous Melanoma
Providence Health & Services 4
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07437963
What this trial is testing

Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse

Who this might be right for
Recurrent GanglioneuroblastomaRecurrent NeuroblastomaRefractory Ganglioneuroblastoma+1 more
National Cancer Institute (NCI) 76
Early research (Phase 1)Study completedNCT00049023
What this trial is testing

Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsGastrointestinal Carcinoid TumorIslet Cell Tumor+4 more
O'Dorisio, M S 27
Early research (Phase 1)Active Not RecruitingNCT02573896
What this trial is testing

Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells

Who this might be right for
Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium 13
Early research (Phase 1)UnknownNCT05540873
What this trial is testing

A Clinical Study of IL13Rα2 Targeted CAR-T in Patients With Malignant Glioma (MAGIC-I)

Who this might be right for
Recurrent Malignant Glioma
CellabMED 18
Testing effectiveness (Phase 2)Study completedNCT02372006
What this trial is testing

Trial of Afatinib in Pediatric Tumours

Who this might be right for
Neuroectodermal TumorsRhabdomyosarcoma
Boehringer Ingelheim 56
Early research (Phase 1)Enrolling By InvitationNCT05650749
What this trial is testing

GPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma and Metastatic Retinoblastoma

Who this might be right for
Refractory NeuroblastomaRelapsed NeuroblastomaHigh-risk Neuroblastoma+2 more
Stephan Grupp MD PhD 45
Early research (Phase 1)Study completedNCT02390843
What this trial is testing

Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors

Who this might be right for
RetinoblastomaClear Cell SarcomaRenal Cell Carcinoma+9 more
Emory University 13
Testing effectiveness (Phase 2)Study completedNCT00541138
What this trial is testing

Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors

Who this might be right for
Brain and Central Nervous System TumorsMetastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
City of Hope Medical Center 50
Testing effectiveness (Phase 2)Ended earlyNCT02664961
What this trial is testing

Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN)

Who this might be right for
Gestational Trophoblastic NeoplasiaChoriocarcinomaPlacental Site Trophoblastic Tumor+1 more
Tracon Pharmaceuticals Inc. 3
Early research (Phase 1)Not Yet RecruitingNCT07455045
What this trial is testing

A Phase I Study of FZ-AD005 in Patients With High-Grade Glioma (HGG)

Who this might be right for
High Grade Glioma (III or IV)Diffuse Midline Glioma (DMG)Glioblastoma (GBM)
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT00010283
What this trial is testing

Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT00450827
What this trial is testing

Iodine I 131 Monoclonal Antibody 3F8 and Bevacizumab in Treating Patients With Relapsed or Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 25
Next Page